Mechanistic study of IR-780 dye as a potential tumor targeting anddrug delivery agent

Biomaterials

Volumn 35, Issue 2, 2014, Pages 771-778

  Zhang, Erlong ^a   Luo, Shenglin ^a   Tan, Xu ^a   Shi, Chunmeng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glycolysis; IR 780 iodide; Nitrogen mustard; OATP1B3; Plasma membrane potential

Indexed keywords

GLYCOLYSIS; IR-780 IODIDE; NITROGEN MUSTARDS; OATP1B3; PLASMA MEMBRANE POTENTIALS;

CELL MEMBRANES; DRUG DELIVERY; MITOCHONDRIA; MOLECULAR BIOLOGY; NITROGEN COMPOUNDS; PATHOLOGY;

TUMORS;

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG CARRIER; IODIDE; IR 780; ORGANIC ANION TRANSPORTER; PRAVASTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENERGY METABOLISM; FEMALE; FLOW CYTOMETRY; GLIOMA CELL; GLYCOLYSIS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RAT;

GLYCOLYSIS; IR-780 IODIDE; NITROGEN MUSTARD; OATP1B3; PLASMA MEMBRANE POTENTIAL;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CELL MEMBRANE; DRUG CARRIERS; ENDOCYTOSIS; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; INDOLES; IODIDES; MECHLORETHAMINE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; NEOPLASM TRANSPLANTATION; ORGANIC ANION TRANSPORTERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84886753427     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.033     Document Type: Article

References (38)

1. Hilderbrand S.A., Weissleder R. Near-infrared fluorescence: application to invivo molecular imaging. Curr Opin Chem Biol 2010, 14:71-79.
2. Luo S., Zhang E., Su Y., Cheng T., Shi C. Areview of NIR dyes in cancer targeting and imaging. Biomaterials 2011, 32:7127-7138.
3. Pansare V., Hejazi S., Faenza W., Prud'homme R.K. Review of long-wavelength optical and NIR imaging materials: contrast agents, fluorophores and multifunctional nano carriers. Chem Mater 2012, 24:812-827.
4. Sevick-Muraca E.M. Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med 2012, 63:217-231.
5. Yuan L., Lin W., Zheng K., He L., Huang W. Far-red to near infrared analyte-responsive fluorescent probes based on organic fluorophore platforms for fluorescence imaging. Chem Soc Rev 2013, 42:622-661.
6. Frangioni J.V. Invivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003, 7:626-634.
7. Troyan S., Kianzad V., Gibbs-Strauss S., Gioux S., Matsui A., Oketokoun R., et al. The FLARE™ intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 2009, 16:2943-2952.
8. Yang X., Shi C., Tong R., Qian W., Zhau H.E., Wang R., et al. Near IR heptamethine cyanine dye-mediated cancer imaging. Clin Cancer Res 2010, 16:2833-2844.
9. Mieog J.S., Troyan S., Hutteman M., Donohoe K., Vorst J., Stockdale A., et al. Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 2011, 18:2483-2491.
10. Mitsunaga M., Ogawa M., Kosaka N., Rosenblum L.T., Choyke P.L., Kobayashi H. Cancer cell-selective invivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med 2011, 17:1685-1691.
11. Choi H.S., Gibbs S.L., Lee J.H., Kim S.H., Ashitate Y., Liu F., et al. Targeted zwitterionic near-infrared fluorophores for improved optical imaging. Nat Biotechnol 2013, 31:148-153.
12. Yue C., Liu P., Zheng M., Zhao P., Wang Y., Ma Y., et al. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Biomaterials 2013, 34:6853-6861.
13. Yang H., Mao H., Wan Z., Zhu A., Guo M., Li Y., et al. Micelles assembled with carbocyanine dyes for theranostic near-infrared fluorescent cancer imaging and photothermal therapy. Biomaterials 2013, 34:9124-9133.
14. Zhang C., Liu T., Su Y., Luo S., Zhu Y., Tan X., et al. Anear-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for invivo imaging. Biomaterials 2010, 31:6612-6617.
15. Zhang E., Zhang C., Su Y., Cheng T., Shi C. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discov Today 2011, 16:140-146.
16. Pathania D., Millard M., Neamati N. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv Drug Deliv Rev 2009, 61:1250-1275.
17. Mo R., Sun Q., Xue J., Li N., Li W., Zhang C., et al. Drug delivery: multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery. Adv Mater 2012, 24:3659-3665.
18. Zhang C., Peng Y., Wang F., Tan X., Liu N., Fan S., et al. Asynthetic cantharidin analog for the enhancement of doxorubicin suppression of stem cell-derived aggressive sarcoma. Biomaterials 2010, 31:9535-9543.
19. Yi L., Zhou C., Wang B., Chen T., Xu M., Xu L., et al. Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells. Int J Oncol 2013, 43:477-484.
20. Hanahan D., Weinberg Robert A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
21. Li L., Geisler I., Chmielewski J., Cheng J.X. Cationic amphiphilic polyproline helixP11LRR targets intracellular mitochondria. JControl Release 2010, 142:259-266.
22. Davis S., Weiss M.J., Wong J.R., Lampidis T.J., Chen L.B. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. JBiol Chem 1985, 260:13844-13850.
23. Johnson L.V., Walsh M.L., Bockus B.J., Chen L.B. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. JCell Biol 1981, 88:526-535.
24. Chen L.B. Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 2003, 4:155-181.
25. Karlgren M., Vildhede A., Norinder U., Wisniewski J.R., Kimoto E., Lai Y., et al. Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. JMed Chem 2012, 55:4740-4763.
26. Lee W., Belkhiri A., Lockhart A.C., Merchant N., Glaeser H., Harris E.I., et al. Overexpression of OATP1B3 confers apoptotic resistance in colon cancer. Cancer Res 2008, 68:10315-10323.
27. Narita M., Hatano E., Arizono S., Miyagawa-Hayashino A., Isoda H., Kitamura K., et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. JGastroenterol 2009, 44:793-798.
28. Hamada A., Sissung T., Price D.K., Danesi R., Chau C.H., Sharifi N., et al. Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin Cancer Res 2008, 14:3312-3318.
29. Shukla S., Wu C.P., Ambudkar S.V. Development of inhibitors of ATP-binding cassette drug transporters - present status and challenges. Expert Opin Drug Met 2008, 4:205-223.
30. Schinkel A.H., Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 2012, 64:138-153.
31. Fischer S., Loncar J., Zaja R., Schnell S., Schirmer K., Smital T., et al. Constitutive mRNA expression and protein activity levels of nine ABC efflux transporters in seven permanent cell lines derived from different tissues of rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 2011, 101:438-446.
32. Rhoads C.P. Nitrogen mustards in the treatment of neoplastic disease: official statement. JAm Med Assoc 1946, 131:656-658.
33. Spitz S. The histological effects of nitrogen mustards on human tumors and tissues. Cancer 1948, 1:383-398.
34. Mattes W.B., Hartley J.A., Kohn K.W. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucleic Acids Res 1986, 14:2971-2987.
35. Polavarapu A., Stillabower J.A., Stubblefield S.G.W., Taylor W.M., Baik M.H. The mechanism of guanine alkylation by nitrogen mustards: a computational study. JOrg Chem 2012, 77:5914-5921.
36. Bethlenfalvay N.C., Bergin J.J. Severe cerebral toxicity after intravenous nitrogen mustard therapy. Cancer 1972, 29:366-369.
37. Yaren H., Mollaoglu H., Kurt B., Korkmaz A., Oter S., Topal T., et al. Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res Vet Sci 2007, 83:116-122.
38. Kumar P., Gautam A., Jatav P.C., kumar A., Ganeshan K., Pathak U., et al. Ameliorative effect of DRDE 07 and its analogues on the systemic toxicity of sulphur mustard and nitrogen mustard in rabbit. Hum Exp Toxicol 2010, 29:747-755.